← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (220)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1457)

• Health-related quality of life of multidrug-resistant tuberculosis patients: A study of eastern Uttar Pradesh, India. (2022/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A buccal mucosa ulcer as the first sign of tuberculosis. (2022/07/01) ♡
• Assessing physical and chemical properties of saliva among tuberculosis patients on anti-tuberculosis treatment - An observational study. (2022/06/22) ♡
• Good citizens, perfect patients, and family reputation: Stigma and prolonged isolation in people with drug-resistant tuberculosis in Vietnam. (2022/06/22) ♡
• Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis. (2022/06/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Spend wisely to eliminate malaria. (2022/06/01) ♡
• Pattern of drug resistant Mycobacterium tuberculosis in the west and northwest of Iran: a meta-analysis. (2022/06/01) ♡
• Implementation of the 'Removed Injectable modified Short-course regimens for EXpert Multidrug Resistant Tuberculosis' (RISE study) in Tanzania: a protocol for a mixed-methods process evaluation. (2022/05/24) ♡
• Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study. (2022/05/14) ♡
• Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we? (2022/04/20) ♡
• Assessment of prevalence of depression and its associated factors among tuberculosis patients in Ernakulam district, Kerala. (2022/04/01) ♡
• Interleukin-37 gene polymorphism and susceptibility to pulmonary tuberculosis among Iraqi patients. (2022/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Drug resistant tuberculosis: Current scenario and impending challenges. (2022/04/01) ♡
• 'Personalizing' shorter regimens: Need of the hour. (2022/04/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study. (2022/04/01) ♡
• Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households. (2022/03/29) ♡
• Deep learning aided quantitative analysis of anti-tuberculosis fixed-dose combinatorial formulation by terahertz spectroscopy. (2022/03/15) ♡
• Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: An institution-based cross-sectional study. (2022/03/10) ♡
• Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study. (2022/03/06) ♡
• Clinical characteristics, common sites and drug resistance profile in culture-confirmed extrapulmonary TB/HIV co-infection patients, Southwest China. (2022/03/01) ♡
• Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis. (2022/03/01) ♡
• Frequency and Factors Associated With Adverse Events Among Multi-Drug Resistant Tuberculosis Patients in Pakistan: A Retrospective Study. (2022/03/01) ♡
• First-line drug resistance profiling of Mycobacterium tuberculosis: a machine learning approach. (2022/02/21) ♡
• Phytochemical screening, antimycobacterial activity and acute toxicity of crude extracts of selected medicinal plant species used locally in the treatment of tuberculosis in Uganda. (2022/02/17) ♡
• Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia. (2022/02/17) ♡
• Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis. (2022/02/05) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance. (2022/02/05) ♡
• Antibacterial, antibiofilm, anti-inflammatory, and wound healing effects of nanoscale multifunctional cationic alternating copolymers. (2022/02/01) ♡
• Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid. (2022/02/01) ♡
• Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia. (2022/01/28) ♡
• Epidemiological Characteristics and Their Influencing Factors Among Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Survey Study From Drug Resistance Surveillance in East China. (2022/01/24) ♡
• Substrate Reduction Therapy for Krabbe Disease: Exploring the Repurposing of the Antibiotic D-Cycloserine. (2022/01/18) ♡
• A Recombinase Polymerase Amplification-Coupled Cas12a Mutant-Based Module for Efficient Detection of Streptomycin-Resistant Mutations in Mycobacterium tuberculosis. (2022/01/06) ♡
• Identification of structurally diverse menaquinone-binding antibiotics with in vivo activity against multidrug-resistant pathogens. (2022/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mapping twenty years of antimicrobial resistance research trends. (2022/01/01) ♡
• Pore formation by pore forming membrane proteins towards infections. (2022/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis with discordant drug resistance patterns- A diagnostic dilemma. (2022/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An Overview of Zinc Oxide Nanoparticles Produced by Plant Extracts for Anti-tuberculosis Treatments. (2022/01/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In vitro, in vivo and in silico rationale for the muscle loss due to therapeutic drugs used in the treatment of Mycobacterium tuberculosis infection. (2022/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Uncommon manifestations in tuberculosis: An expanding clinical spectrum from North India. (2022/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Drug resistant tuberculosis among elderly: Challenges. (2022/01/01) ♡
• CAUSES OF SUPERINFECTIONS: DEADLY BACTERIA OF TUBERCULOSIS. (2022/01/01) ♡
• Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries. (2022/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis (2022-11-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB (2022-10-12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Expand New Drugs for TB [endTB] (2022-06-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis (2022-06-01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis (2022-05-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Bone Resistant Tuberculosis (2022-05-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance (2022-03-29) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.